Mortality and loss to follow-up among HAART initiators in rural South Africa
- PMID: 19012940
- DOI: 10.1016/j.trstmh.2008.10.001
Mortality and loss to follow-up among HAART initiators in rural South Africa
Abstract
A retrospective cohort study of mortality rates and potential predictors of death was conducted in public-sector patients initiating highly active antiretroviral therapy (HAART) between October 2005 and September 2007 in a rural, under-resourced region of South Africa. The aims were to determine the relative contribution of death to cohort exit and the causes and predictors of mortality among HAART initiators. A community outreach programme traced non-attenders. Patients categorised as dying at home underwent a verbal autopsy (by interviewing family members) and case-file review, and those dying in hospital a case-file review, to determine the probable cause of death. At 24 months 1131 (83.6%) patients were retained on treatment in the programme, 124 (9.2%) had died, 63 (4.7%) had transferred out, and 35 (2.6%) were lost to follow-up. The most common causes of death were tuberculosis (44.3%) and diarrhoeal diseases (24.5%). Death was the major reason for cohort exit. As experience is gained with rural HAART programmes mortality rates may decrease. These results draw attention to the need for early HIV diagnosis, increased access to HAART services with earlier treatment initiation, and routine screening and aggressive management of opportunistic infections, particularly tuberculosis.
Similar articles
-
Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.AIDS. 2006 May 12;20(8):1181-9. doi: 10.1097/01.aids.0000226959.87471.01. AIDS. 2006. PMID: 16691070
-
Effectiveness of antiretroviral treatment in a South African program: a cohort study.Arch Intern Med. 2008 Jan 14;168(1):86-93. doi: 10.1001/archinternmed.2007.10. Arch Intern Med. 2008. PMID: 18195200
-
Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.AIDS. 2010 Feb 20;24(4):563-72. doi: 10.1097/QAD.0b013e328333bfb7. AIDS. 2010. PMID: 20057311
-
Autopsy causes of death in HIV-positive individuals in sub-Saharan Africa and correlation with clinical diagnoses.AIDS Rev. 2010 Oct-Dec;12(4):183-94. AIDS Rev. 2010. PMID: 21179183 Review.
-
[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Epub 2009 Feb 26. Enferm Infecc Microbiol Clin. 2009. PMID: 19246124 Spanish.
Cited by
-
Attrition among human immunodeficiency virus (HIV)- infected patients initiating antiretroviral therapy in China, 2003-2010.PLoS One. 2012;7(6):e39414. doi: 10.1371/journal.pone.0039414. Epub 2012 Jun 27. PLoS One. 2012. PMID: 22761787 Free PMC article.
-
Retention in a NGO supported antiretroviral program in the Democratic Republic of Congo.PLoS One. 2012;7(7):e40971. doi: 10.1371/journal.pone.0040971. Epub 2012 Jul 17. PLoS One. 2012. PMID: 22815883 Free PMC article.
-
Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.PLoS One. 2011;6(12):e27919. doi: 10.1371/journal.pone.0027919. Epub 2011 Dec 19. PLoS One. 2011. PMID: 22205933 Free PMC article.
-
A South African public-private partnership HIV treatment model: viability and success factors.PLoS One. 2014 Oct 20;9(10):e110635. doi: 10.1371/journal.pone.0110635. eCollection 2014. PLoS One. 2014. PMID: 25329384 Free PMC article.
-
Mortality and Its Predictors among HIV Infected Patients Taking Antiretroviral Treatment in Ethiopia: A Systematic Review.AIDS Res Treat. 2017;2017:5415298. doi: 10.1155/2017/5415298. Epub 2017 Oct 30. AIDS Res Treat. 2017. PMID: 29214077 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials